Trial Profile
Pregabalin for the Treatment of Pain After Posterior Spinal Fusions.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2022
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 23 Jul 2012 Actual end date (1 Feb 2012) added as reported by ClinicalTrials.gov.
- 01 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jun 2011 New trial record